While targeted therapies have shown high clinical efficacy in inhibiting IL-23 and IL-17, psoriasis is still a treatable but non curable disease. Other drugs targeting TNF-a and interleukin receptors aim to stop the inflammation. Central BioHub supports scientists investigating these pathways with well-characterized high quality psoriasis samples that can be utilized for research.